Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

AGM trading update

25 Sep 2025 07:00

RNS Number : 7206A
Babcock International Group PLC
25 September 2025
 

25 September 2025

 

Babcock International Group PLC

AGM trading update

 

Continued positive momentum, full year expectations unchanged

 

Babcock International Group ("Babcock" or "the Group") provides a trading update for the first five months of the financial year ahead of its Annual General Meeting to be held at 11.00 am today.

Trading update to 31 August 2025

Trading in the first five months to 31 August 2025 has been encouraging, with the Group delivering organic revenue growth and underlying operating margin progress in line with the Board's expectations.

Strong growth in Nuclear, driven by civil nuclear projects and submarine support, and Aviation, as a result of the ramp-up of the French Mentor 2 contract, and ongoing growth in Marine was partly offset by lower revenue in Land, due to lower activity in the Rail business.

Overall, expectations for the full year remain unchanged and we continue to progress towards the Group's medium-term guidance, which we upgraded in June 2025 to average revenue growth of mid-single digit, underlying operating margin of at least 9% (previously at least 8%) and average operating cash conversion of at least 80%.

Developments in the period

The macro environment remains supportive, and we continue to make good strategic progress. In the period we welcomed the UK Government's Defence Industrial Strategy, which strongly aligns with our capabilities. Babcock's business momentum has continued through the period with sustained delivery and strategic progress to support future growth.

· Type 31 frigate programme - in April we were awarded a c£65 million Capability Insertion Programme contract on a sole source basis. In June, a major milestone was reached with float-off of the first ship, HMS Venturer. The second ship, HMS Active, is on track to float-off before the end of FY26.

 

· Submarine disposal - in June we secured a £114 million contract to support the first defueling of a decommissioned British nuclear submarine in over 20 years. We will work with the UK Defence Nuclear Enterprise and industry partners to prepare for the defuel of four decommissioned submarines at our Devonport facility from 2026.

 

· AUKUS - our joint venture with HII in Australia secured its first contract to enhance Australia's supply chain capabilities in preparation for delivery of the first three nuclear-powered submarines under the trilateral partnership.

 

· Australia - in September we signed a new AU$250 million, 8-year follow-on contract with the Australian Border Force (ABF) to enhance maritime security operations in the Torres Strait. The contract includes the delivery of two mission modified Airbus H145 helicopters to the ABF, plus air crews and ongoing maintenance over eight years.

 

· New AI intelligence product - in September we launched our first fully AI-powered communications intelligence product NomadTM which provides front-line military and security services with valuable intelligence in real-time.

 

· Significant industry partnerships - we announced collaborations with leading global industry players, including: a Memorandum of Understanding (MoU) with BAE Systems Bofurs to offer support for the Type 31's multi-purpose Bofurs guns; as UK build partner to Finnish armoured vehicle company Patria following the UK MOD's arrangement to join the multinational Common Armoured Vehicle System programme; as Hanwha Ocean's exclusive in-service support partner for the new Canadian Patrol Submarine Project; as HII's partner to deliver autonomous launch and recovery of Unmanned Underwater Vehicles via submarine torpedo tubes and; an MoU with radio communications equipment manufacturer KNL to offer next generation high frequency communications support to armed forces across the land, sea and air domains.

 

· Share buybacks - we have completed around 25% of the £200 million share buyback programme announced at our preliminary results on 25 June 2025. We expect the programme to conclude by the end of FY26.

 

· Refinancing of the Revolving Credit Facility (RCF) - in July, we successfully entered into a new RCF with ten banks which replaces the previous financing facility of £775 million. The new committed debt facility, which is valid for five years with 2 one-year extension options, will provide the Group with access to borrowings of up to an aggregate amount of £600 million, with an accordion option to increase this facility by up to £200 million at lenders discretion.

Additionally, during the period we held the first two of a series of investor events. These demonstrated potential for both our Marine Design and Build business and our Cavendish Nuclear business to double revenues by 2030. Links to the materials and event replays can be found on our website at www.babcockinternational.com/investors

HY26 half year results

The Group's HY26 half year results will be published on 20 November 2025.

 

 

ENDS

 

For further information:

Andrew Gollan, Director of Investor Relations +44 (0)7936 039004

Kate Hill, Group Head of Financial Communications +44 (0)20 7355 5312

Harry Cameron/Camilla Cunningham, Teneo +44 (0)20 7353 4200 

 

 

Certain statements in this announcement are forward-looking statements. Such statements may relate to Babcock's business, strategy and plans. Statements that are not historical facts, including statements about Babcock's or its management's beliefs and expectations, are forward-looking statements. Words such as 'believe', 'anticipate', 'estimates', 'expects', 'intends', 'aims', 'potential', 'will', 'would', 'could', 'considered', 'likely', and variations of these words and similar future or conditional expressions are intended to identify forward-looking statements but are not the exclusive means of doing so. By their nature, forward-looking statements involve a number of risks, uncertainties or assumptions, some known and some unknown, many of which are beyond Babcock's control that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties or assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nor are they indicative of future performance and Babcock's actual results of operations and financial condition and the development of the industry and markets in which Babcock operates may differ materially from those made in or suggested by the forward-looking statements. You should not place undue reliance on forward-looking statements because such statements relate to events and depend on circumstances that may or may not occur in the future. Except as required by law, Babcock is under no obligation to update (and will not) or keep current the forward-looking statements contained herein or to correct any inaccuracies which may become apparent in such forward-looking statements. 

Forward-looking statements reflect Babcock's judgement at the time of preparation of this announcement and are not intended to give any assurance as to future results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZLGDLGKZZ
Date   Source Headline
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.